Đang chuẩn bị liên kết để tải về tài liệu:
Báo cáo khoa học: " Squamous cell carcinoma of the prostate: long-term survival after combined chemo-radiation"

Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Radiation Oncology cung cấp cho các bạn kiến thức về ngành y đề tài: " Squamous cell carcinoma of the prostate: long-term survival after combined chemo-radiation. | Radiation Oncology BioMed Central Open Access Short report Squamous cell carcinoma of the prostate long-term survival after combined chemo-radiation Fernando Munoz1 Pierfrancesco Franco 1 Patrizia Ciammella1 Mario Clerico2 Mauro Giudici3 Andrea Riccardo Filippi1 and Umberto Ricardi1 Address Department of Medical and Surgical Sciences Radiation Oncology Unit University of Torino Ospedale S. Giovanni Battista Torino Italy 2Department of Oncology Medical Oncology ASL 12 Biella Italy and 3Pathology Unit ASL 12 Biella Italy Email Fernando Munoz - fmunoz@iol.it Pierfrancesco Franco - pier4377@yahoo.it Patrizia Ciammella - patriziaciammella@yahoo.it Mario Clerico - mario.clerico@asl12.piemonte.it Mauro Giudici - mauro.giudici@asl12.piemonte.it Andrea Riccardo Filippi - andrea.filippi@unito.it Umberto Ricardi - umberto.ricardi@unito.it Corresponding author Published 3 April 2007 Received 2 February 2007 Radiation Oncology 2007 2 15 doi 10.1186 1748-717X-2-15 Accepted 3 April 2007 This article is available from http www.ro-journal.cOm content 2 1 15 2007 Munoz et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http creativecommons.org licenses by 2.0 which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract__ Background Carcinoma of the prostate gland is the most frequent malignant tumour affecting male population. While the large majority of tumours is represented by adenocarcinoma pure squamous cell carcinoma comprises only 0 5-1 of all prostate neoplastic lesions. It is characterised by a high degree of malignancy commonly metastasising to the bone mainly with osteolytic lesions liver and lungs with a median survival time of 14 months. Several therapeutic approaches have been employed in the effort to treat prostate pure squamous cell